Sartorius Stedim Biotech S.A. (OTCMKTS:SDMHF – Get Free Report) fell 5.9% during mid-day trading on Thursday . The stock traded as low as $183.95 and last traded at $192.00. Approximately 244 shares were traded during mid-day trading, a decline of 90% from the average session volume of 2,401 shares. The stock had previously closed at $204.00.
Sartorius Stedim Biotech Stock Performance
The stock’s 50 day moving average is $199.39 and its 200 day moving average is $215.08.
About Sartorius Stedim Biotech
Sartorius Stedim Biotech SA (OTCMKTS: SDMHF) is a global provider of bioprocessing equipment and services for the biopharmaceutical industry. The company develops and manufactures technologies that support the development and production of vaccines, monoclonal antibodies, therapeutic proteins and cell? and gene?based therapies. Its solutions address both upstream processes—such as cell cultivation and fermentation—and downstream processes, including filtration, centrifugation and chromatography.
Key product offerings include single?use bioreactors and mixers, modular filtration assemblies, prepacked chromatography columns, and a wide range of cell culture media and buffer systems.
Featured Articles
- Five stocks we like better than Sartorius Stedim Biotech
- MarketBeat Week in Review – 06/15 – 06/19
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
Receive News & Ratings for Sartorius Stedim Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Stedim Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
